Managers / Q2 2020 · view latest →
Clarus Wealth Advisors
CIK 0001730149 · 9125 W. THUNDERBIRD ROAD, SUITE100, PEORIA, AZ, 85381 · 6233027706
Summary
Clarus Wealth Advisors reported $119M in U.S.-listed holdings across 127 positions for Q2 2020.
Its largest position, Spdr, represents 12.0% of the portfolio.
Compared with Q1 2020, the fund opened 35 new positions and exited 22.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 72.7% · $86M
- Common Stock · 26.5% · $31M
- Other · 0.4% · $454,000
- REIT · 0.2% · $294,000
- ADR · 0.2% · $202,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SPDR SER TR | NEW | +59.2K | 59.2K | +$2M | $2M |
| SPDR SER TR | NEW | +51.1K | 51.1K | +$2M | $2M |
| INVESCO EXCHANGE TRADED FD T | NEW | +7.5K | 7.5K | +$763,000 | $763,000 |
| FIRST TR EXCHANGE-TRADED FD | NEW | +11.2K | 11.2K | +$579,000 | $579,000 |
| RTXRAYTHEON TECHNOLOGIES CORP | NEW | +8.1K | 8.1K | +$496,000 | $496,000 |
| FIRST TR EXCHANGE-TRADED FD | NEW | +8.0K | 8.0K | +$479,000 | $479,000 |
| INOVIO PHARMACEUTICALS INC | NEW | +18.0K | 18.0K | +$434,000 | $434,000 |
| TJXTJX COS INC NEW | NEW | +6.8K | 6.8K | +$343,000 | $343,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | PRTFLO S&P500 GW · S&P 600 SMCP GRW · S&P 400 MDCP GRW · S&P 400 MDCP VAL · S&P 600 SMCP VAL · PORTFOLIO S&P500 · HLTH CR EQUIP · AEROSPACE DEF | 35.78% | $42M | 849.0K |
| 2 | ACWIISHARES TR | CORE US AGGBD ET · RUS MID CAP ETF · IBOXX INV CP ETF · S&P 500 VAL ETF · USA MOMENTUM FCT · MSCI ACWI ETF · NASDAQ BIOTECH · TRANS AVG ETF · 20 YR TR BD ETF | 9.45% | $11M | 109.3K |
| 3 | XLESELECT SECTOR SPDR TR | TECHNOLOGY · SBI CONS DISCR · SBI CONS STPLS · ENERGY · SBI HEALTHCARE · COMMUNICATION | 5.39% | $6M | 82.2K |
| 4 | AAPLAPPLE INChistory → | COM | 5.06% | $6M | 16.1K |
| 5 | VUGVANGUARD INDEX FDS | TOTAL STK MKT · GROWTH ETF · SML CP GRW ETF | 3.65% | $4M | 23.9K |
| 6 | SPDR S&P 500 ETF TR | TR UNIT | 2.55% | $3M | 9.7K |
| 7 | LMTLOCKHEED MARTIN CORPhistory → | COM | 2.42% | $3M | 8.1K |
| 8 | NDQINVESCO QQQ TRhistory → | UNIT SER 1 | 1.99% | $2M | 9.1K |
| 9 | FIRST TR EXCHANGE TRADED FD | US EQTY OPPT ETF · FST LOW OPPT EFT · FST TR GLB FD · TECH ALPHADEX | 1.99% | $2M | 60.1K |
| 10 | AMZNAMAZON COM INChistory → | COM | 1.91% | $2M | 756 |
| 11 | NFLXNETFLIX INChistory → | COM | 1.46% | $2M | 3.5K |
| 12 | MSFTMICROSOFT CORPhistory → | COM | 1.01% | $1M | 5.7K |
| 13 | VRTXVERTEX PHARMACEUTICALS INChistory → | COM | 1.01% | $1M | 4.0K |
| 14 | VANGUARD WORLD FD | MEGA GRWTH IND | 0.94% | $1M | 6.6K |
| 15 | TMOTHERMO FISHER SCIENTIFIC INC | COM | 0.89% | $1M | 2.8K |
| 16 | INVESCO EXCHANGE TRADED FD T | S&P500 EQL WGT | 0.64% | $763,000 | 7.5K |
| 17 | CHVCHEVRON CORP NEW | COM | 0.64% | $755,000 | 8.8K |
| 18 | GILDGILEAD SCIENCES INC | COM | 0.58% | $686,000 | 9.0K |
| 19 | BIIBBIOGEN INC | COM | 0.57% | $682,000 | 2.5K |
| 20 | SRPTSAREPTA THERAPEUTICS INC | COM | 0.51% | $601,000 | 3.7K |
| 21 | AMGNAMGEN INC | COM | 0.49% | $583,000 | 2.3K |
| 22 | BABOEING CO | COM | 0.49% | $578,000 | 3.2K |
| 23 | FIRST TR VALUE LINE DIVID IN | SHS | 0.44% | $521,000 | 17.2K |
| 24 | ATVIEURACTIVISION BLIZZARD INC | COM | 0.43% | $515,000 | 6.6K |
| 25 | VVISA INC | COM CL A | 0.43% | $507,000 | 2.6K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $235M | 88 | Apr 8, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $241M | 86 | Jan 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $226M | 86 | Oct 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $216M | 87 | Jul 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $187M | 88 | Apr 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $201M | 119 | Jan 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $196M | 134 | Oct 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $188M | 130 | Jul 11, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $177M | 130 | Apr 11, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $169M | 124 | Jan 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $165M | 124 | Jul 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $159M | 125 | Apr 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $153M | 115 | Jan 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $140M | 107 | Oct 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $142M | 98 | Jul 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $161M | 109 | Apr 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $174M | 104 | Jan 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $163M | 103 | Oct 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $160M | 100 | Jul 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $160M | 130 | Apr 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $150M | 131 | Jan 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $129M | 124 | Oct 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $119M | 127 | Jul 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $100M | 114 | Apr 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $151M | 141 | Jan 10, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2019 | $137M | 145 | Oct 11, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $138M | 600 | Jul 24, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $134M | 684 | Apr 4, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $64M | 685 | Feb 5, 2019 | RESTATEMENT | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.